Abstract
Acute myeloid leukemia (AML) is, as other types of cancer, a genetic disorder of somatic cells. The detection of somatic molecular abnormalities that may cause and maintain AML is crucial for patient stratification. The development of mutation-specific therapeutic interventions will hopefully increase cure rates and improve patients' quality of life. This review illustrates how next generation sequencing technologies are changing the study of cancer genomics of adult AML patients.
| Original language | English |
|---|---|
| Article number | Article 40 |
| Journal | Frontiers in Oncology |
| Volume | 2 MAY |
| DOIs | |
| Publication status | Published - 2012 |
Keywords
- Acute myeloid leukemia
- Next generation sequencing
- Recurrent mutations
- Somatic mutations
ASJC Scopus subject areas
- Cancer Research
- Oncology
Fingerprint Dive into the research topics of 'Genomics of acute myeloid leukemia: The next generation'. Together they form a unique fingerprint.
Cite this
Riva, L., Luzi, L., & Pelicci, P. G. (2012). Genomics of acute myeloid leukemia: The next generation. Frontiers in Oncology, 2 MAY, [Article 40]. https://doi.org/10.3389/fonc.2012.00040